Myeloid-derived suppressor cells in bacterial infections

Frontiers in Cellular and Infection Microbiology

Volumn 6, Issue MAR, 2016, Pages

  Ost, Michael ^a   Singh, Anurag ^a   Peschel, Andreas ^a   Mehling, Roman ^a   Rieber, Nikolaus ^a,b   Hartl, Dominik ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacteria; Immune suppression; Infection; MDSC; Myeloid derived suppressor cells; Sepsis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; PATTERN RECOGNITION RECEPTOR; SORAFENIB; STAT3 PROTEIN; SUNITINIB; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; CELL ACTIVATION; CELL EXPANSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE SEVERITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; LUNG FUNCTION; MELANOMA; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEPSIS; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; SUPPRESSOR CELL; TUBERCULOSIS; IMMUNOLOGY; MACROPHAGE; MONOCYTE; NEUTROPHIL; T LYMPHOCYTE;

BACTERIAL INFECTIONS; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; MONOCYTES; NEUTROPHILS; T-LYMPHOCYTES;

EID: 85006200850     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2016.00037     Document Type: Short Survey

References (136)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801. doi: 10.1016/j.cell.2006.02.015.
2. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., et al. (2001). Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689. doi: 10.4049/jimmunol.166.1.678.
3. Aranda, F., Vacchelli, E., Obrist, F., Eggermont, A., Galon, J., Sautes-Fridman, C., et al. (2014). Trial Watch: toll-like receptor agonists in oncological indications. Oncoimmunology 3:e29179. doi: 10.4161/onci.29179.
4. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., et al. (2002). Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034. doi: 10.1074/jbc. M200497200.
5. Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., et al. (2003). IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 170, 270-278. doi: 10.4049/jimmunol.170.1.270.
6. Brudecki, L., Ferguson, D. A., McCall, C. E., and El Gazzar, M. (2012). Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80, 2026-2034. doi: 10.1128/IAI.00239-12.
7. Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., and Ostrand-Rosenberg, S. (2009). Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J. Leukoc. Biol. 85, 996-1004. doi: 10.1189/jlb.0708446.
8. Cai, S., Batra, S., Shen, L., Wakamatsu, N., and Jeyaseelan, S. (2009). Both TRIF-and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183, 6629-6638. doi: 10.4049/jimmunol.0901033.
9. Cai, W., Qin, A., Guo, P., Yan, D., Hu, F., Yang, Q., et al. (2013). Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 33, 798-808. doi: 10.1007/s10875-012-9861-2.
10. Cao, M., Xu, Y., Youn, J. I., Cabrera, R., Zhang, X., Gabrilovich, D., et al. (2011). Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Lab. Invest. 91, 598-608. doi: 10.1038/labinvest.2010.205.
11. Chen, M. F., Kuan, F. C., Yen, T. C., Lu, M. S., Lin, P. Y., Chung, Y. H., et al. (2014). IL-6-stimulated CD11b+ CD14+ HLA-DR-myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget 5, 8716-8728. doi: 10.18632/oncotarget.2368.
12. Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., et al. (2008). Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205, 2235-2249. doi: 10.1084/jem.20080132.
13. Cohen, T. S., and Prince, A. (2012). Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18, 509-519. doi: 10.1038/nm.2715.
14. Condamine, T., Kumar, V., Ramachandran, I. R., Youn, J. I., Celis, E., Finnberg, N., et al. (2014). ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J. Clin. Invest. 124, 2626-2639. doi: 10.1172/JCI74056.
15. Condamine, T., Mastio, J., and Gabrilovich, D. I. (2015). Transcriptional regulation of myeloid-derived suppressor cells. J. Leukoc. Biol. 98, 913-922. doi: 10.1189/jlb.4RI0515-204R.
16. Darcy, C. J., Minigo, G., Piera, K. A., Davis, J. S., McNeil, Y. R., Chen, Y., et al. (2014). Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit. Care 18:R163. doi: 10.1186/cc14003.
17. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., et al. (2007). MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474. doi: 10.1084/jem.20062602.
18. Derive, M., Bouazza, Y., Alauzet, C., and Gibot, S. (2012). Myeloid-derived suppressor cells control microbial sepsis. Intensive Care Med. 38, 1040-1049. doi: 10.1007/s00134-012-2574-4.
19. Dietlin, T. A., Hofman, F. M., Lund, B. T., Gilmore, W., Stohlman, S. A., and van der Veen, R. C. (2007). Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. J. Leukoc Biol. 81, 1205-1212. doi: 10.1189/jlb.1006640.
20. Dugast, A. S., Haudebourg, T., Coulon, F., Heslan, M., Haspot, F., Poirier, N., et al. (2008). Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 180, 7898-7906. doi: 10.4049/jimmunol.180.12.7898.
21. Du Plessis, N., Loebenberg, L., Kriel, M., von Groote-Bidlingmaier, F., Ribechini, E., Loxton, A. G., et al. (2013). Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function. Am. J. Respir. Crit. Care Med. 188, 724-732. doi: 10.1164/rccm.201302-0249OC.
22. El Daker, S., Sacchi, A., Tempestilli, M., Carducci, C., Goletti, D., Vanini, V., et al. (2015). Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level. PLoS ONE 10:e0123772. doi: 10.1371/journal.pone.0123772.
23. Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., et al. (2006). TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J. Immunol. 177, 4763-1472. doi: 10.4049/jimmunol.177.7.4763.
24. Fedtke, I., Gotz, F., and Peschel, A. (2004). Bacterial evasion of innate host defenses-the Staphylococcus aureus lesson. Int. J. Med. Microbiol. 294, 189-194. doi: 10.1016/j.ijmm.2004.06.016.
25. Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., et al. (2007). Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546-2553. doi: 10.1200/JCO.2006.08.5829.
26. Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc Biol. 81, 28-37. doi: 10.1189/jlb.0306170.
27. Foster, T. J. (2004). The Staphylococcus aureus "superbug". J. Clin. Invest. 114, 1693-1696. doi: 10.1172/JCI23825.
28. Franchi, L., Stoolman, J., Kanneganti, T. D., Verma, A., Ramphal, R., and Nunez, G. (2007). Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur. J. Immunol. 37, 3030-3039. doi: 10.1002/eji.200737532.
29. Gabrilovich, D. I., Bronte, V., Chen, S. H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., et al. (2007). The terminology issue for myeloid-derived suppressor cells. Cancer Res 67, 425. doi: 10.1158/0008-5472.CAN-06-3037.
30. Gabrilovich, D. I., and Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174. doi: 10.1038/nri2506.
31. Gabrilovich, D. I., Ostrand-Rosenberg, S., and Bronte, V. (2012). Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268. doi: 10.1038/nri3175.
32. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., et al. (1998). Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166.
33. Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., and Kast, W. M. (2001). Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166, 5398-406. doi: 10.4049/jimmunol.166.9.5398.
34. Garban, H. J., and Bonavida, B. (2001). Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J. Immunol. 167, 75-81. doi: 10.4049/jimmunol.167.1.75.
35. Garg, A., and Spector, S. A. (2014). HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J. Infect. Dis. 209, 441-451. doi: 10.1093/infdis/jit469.
36. Goh, C. C., Roggerson, K. M., Lee, H. C., Golden-Mason, L., Rosen, H. R., and Hahn, Y. S. (2016). Hepatitis C virus-induced myeloid-derived suppressor cells suppress NK Cell IFN-gamma production by altering cellular metabolism via Arginase-1. J. Immunol. 196, 2283-2292. doi: 10.4049/jimmunol.1501881.
37. Goh, C., Narayanan, S., and Hahn, Y. S. (2013). Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? Immunol. Rev. 255, 210-221. doi: 10.1111/imr.12084.
38. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Kruger, C., Bachmann, O., Westendorf, A. M., et al. (2008). Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135, 871-881, 81 e1-5. doi: 10.1053/j.gastro.2008.06.032.
39. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., et al. (2001). The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103. doi: 10.1038/35074106.
40. Heim, C. E., Vidlak, D., and Kielian, T. (2015a). Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection. J. Leukoc. Biol. 98, 1003-1013. doi: 10.1189/jlb.4VMA0315-125RR.
41. Heim, C. E., Vidlak, D., Scherr, T. D., Hartman, C. W., Garvin, K. L., and Kielian, T. (2015b). IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection. J. Immunol. 194, 3861-3872. doi: 10.4049/jimmunol.1402689.
42. Heim, C. E., Vidlak, D., Scherr, T. D., Kozel, J. A., Holzapfel, M., Muirhead, D. E., et al. (2014). Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. J. Immunol. 192, 3778-3792. doi: 10.4049/jimmunol.1303408.
43. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745. doi: 10.1038/35047123.
44. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., et al. (2008). A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135, 234-243. doi: 10.1053/j.gastro.2008.03.020.
45. Hong, E. H., Chang, S. Y., Lee, B. R., Kim, Y. S., Lee, J. M., Kang, C. Y., et al. (2013). Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells. Int. J. Cancer 132, 2839-2848. doi: 10.1002/ijc.27974.
46. Hu, X., Li, B., Li, X., Zhao, X., Wan, L., Lin, G., et al. (2014). Transmembrane TNF-alpha promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. J. Immunol. 192, 1320-1331. doi: 10.4049/jimmunol.1203195.
47. Janeway, C. A. Jr., and Medzhitov, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216. doi: 10.1146/annurev.immunol.20.083001.084359.
48. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A. M., Ryden, L., Bjornsson, S., et al. (2014). A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96, 685-693. doi: 10.1189/jlb.5HI0214-074R.
49. Jassal, M. S., and Bishai, W. R. (2010). Epidemiology and challenges to the elimination of global tuberculosis. Clin. Infect. Dis. 50 (Suppl. 3), S156-S164. doi: 10.1086/651486.
50. Jones, R. N. (2010). Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 51, S81-S87. doi: 10.1086/653053.
51. Kanno, K., Hirata, Y., Imai, T., Iwashina, M., and Marumo, F. (1994). Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am. J. Physiol. 267(6 Pt 2), H2318-H2324.
52. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384. doi: 10.1038/ni.1863.
53. Knaul, J. K., Jorg, S., Oberbeck-Mueller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., et al. (2014). Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 190, 1053-1066. doi: 10.1164/rccm.201405-0828OC.
54. Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., et al. (2009). Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15, 2148-2157. doi: 10.1158/1078-0432.CCR-08-1332.
55. Kruger, P., Saffarzadeh, M., Weber, A. N., Rieber, N., Radsak, M., von Bernuth, H., et al. (2015). Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog. 11:e1004651. doi: 10.1371/journal.ppat.1004651.
56. Kwon, G., Corbett, J. A., Rodi, C. P., Sullivan, P., and McDaniel, M. L. (1995). Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 136, 4790-4795. doi: 10.1210/endo.136.11.7588208.
57. Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., et al. (2003). 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med. 29, 530-538. doi: 10.1007/s00134-003-1662-x.
58. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., et al. (2009). IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 182, 6562-6568. doi: 10.4049/jimmunol.0803831.
59. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554. doi: 10.1056/NEJMoa022139.
60. Martino, A., Badell, E., Abadie, V., Balloy, V., Chignard, M., Mistou, M. Y., et al. (2010). Mycobacterium bovis bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. 184, 2038-2047. doi: 10.4049/jimmunol.0903348.
61. Maruyama, A., Shime, H., Takeda, Y., Azuma, M., Matsumoto, M., and Seya, T. (2015). Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. Biochem. Biophys. Res. Commun. 457, 445-450. doi: 10.1016/j.bbrc.2015.01.011.
62. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., et al. (2002). Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168, 689-695. doi: 10.4049/jimmunol.168.2.689.
63. McClure, C., Brudecki, L., Ferguson, D. A., Yao, Z. Q., Moorman, J. P., McCall, C. E., et al. (2014). MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect. Immun. 82, 3816-3825. doi: 10.1128/IAI.01495-14.
64. Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., et al. (2006). All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 66, 9299-9307. doi: 10.1158/0008-5472.CAN-06-1690.
65. Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., et al. (2011). Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J. Exp. Med. 208, 1949-1962. doi: 10.1084/jem.20101956.
66. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., et al. (2008). Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233-4244. doi: 10.1182/blood-2007-07-099226.
67. Munera, V., Popovic, P. J., Bryk, J., Pribis, J., Caba, D., Matta, B. M., et al. (2010). Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251, 120-126. doi: 10.1097/SLA.0b013e3181bfda1c.
68. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., et al. (2007). Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 13, 828-835. doi: 10.1038/nm1609.
69. Nagaraj, S., Nelson, A., Youn, J. I., Cheng, P., Quiceno, D., and Gabrilovich, D. I. (2012). Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 72, 928-938. doi: 10.1158/0008-5472.CAN-11-2863.
70. Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E., and Gabrilovich, D. I. (2010a). Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184, 3106-3116. doi: 10.4049/jimmunol.0902661.
71. Nagaraj, S., Youn, J. I., and Gabrilovich, D. I. (2013). Reciprocal relationship between myeloid-derived suppressor cells and T cells. J. Immunol. 191, 17-23. doi: 10.4049/jimmunol.1300654.
72. Nagaraj, S., Youn, J. I., Weber, H., Iclozan, C., Lu, L., Cotter, M. J., et al. (2010b). Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin. Cancer Res. 16, 1812-1823. doi: 10.1158/1078-0432.CCR-09-3272.
73. Nguyen, M. T., Kraft, B., Yu, W., Demicrioglu, D. D., Hertlein, T., Burian, M., et al. (2015). The nuSaalpha Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells. PLoS Pathog 11:e1004984. doi: 10.1371/journal.ppat.1004984.
74. Norris, B. A., Uebelhoer, L. S., Nakaya, H. I., Price, A. A., Grakoui, A., and Pulendran, B. (2013). Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38, 309-321. doi: 10.1016/j.immuni.2012.10.022.
75. Obregon-Henao, A., Henao-Tamayo, M., Orme, I. M., and Ordway, D. J. (2013). Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection. PLoS ONE 8:e80669. doi: 10.1371/journal.pone.0080669.
76. Ochoa, A. C., Zea, A. H., Hernandez, C., and Rodriguez, P. C. (2007). Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13(2 Pt 2):721s-726s. doi: 10.1158/1078-0432.CCR-06-2197.
77. Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., and Clements, V. K. (2012). Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 22, 275-281. doi: 10.1016/j.semcancer.2012.01.011.
78. Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., et al. (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 13766-13771. doi: 10.1073/pnas.250476497.
79. Poe, S. L., Arora, M., Oriss, T. B., Yarlagadda, M., Isse, K., Khare, A., et al. (2013). STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol. 6, 189-199. doi: 10.1038/mi.2012.62.
80. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
81. Qin, A., Cai, W., Pan, T., Wu, K., Yang, Q., Wang, N., et al. (2013). Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87, 1477-1490. doi: 10.1128/JVI.01759-12.
82. Qin, C. L., Huang, W., Zhou, S. Q., Wang, X. C., Liu, H. H., Fan, M. H., et al. (2014). Characterization of a novel antimicrobial peptide with chitin-biding domain from Mytilus coruscus. Fish Shellfish Immunol. 41, 362-370. doi: 10.1016/j.fsi.2014.09.019.
83. Rieber, N., Brand, A., Hector, A., Graepler-Mainka, U., Ost, M., Schäfer, I., et al. (2013). Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Disease. J. Immunol. 190, 1276-1284. doi: 10.4049/jimmunol.1202144.
84. Rieber, N., Singh, A., Oz, H., Carevic, M., Bouzani, M., Amich, J., et al. (2015). Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells. Cell Host Microbe 17, 507-514. doi: 10.1016/j.chom.2015.02.007.
85. Roth, F., De La Fuente, A. C., Vella, J. L., Zoso, A., Inverardi, L., and Serafini, P. (2012). Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression. Cancer Res 72, 1373-1383. doi: 10.1158/0008-5472.CAN-11-2772.
86. Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., and Murray, P. J. (2001). Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173-2177. doi: 10.4049/jimmunol.166.4.2173.
87. Sade-Feldman, M., Kanterman, J., Ish-Shalom, E., Elnekave, M., Horwitz, E., and Baniyash, M. (2013). Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38, 541-554. doi: 10.1016/j.immuni.2013.02.007.
88. Saeed, K., Marsh, P., and Ahmad, N. (2014). Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection? Curr. Opin. Infect. Dis. 27, 130-136. doi: 10.1097/QCO.0000000000000046.
89. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Muller, M., et al. (2010). Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464. doi: 10.1084/jem.20091474.
90. Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., et al. (2008). Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457-5466. doi: 10.1182/blood-2008-01-136895.
91. Schreiner, J., Kretschmer, D., Klenk, J., Otto, M., Buhring, H. J., Stevanovic, S., et al. (2013). Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J. Immunol. 190, 3417-3426. doi: 10.4049/jimmunol.1202563.
92. Serafini, P. (2013). Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly. Immunol. Res. 57, 172-184. doi: 10.1007/s12026-013-8455-2.
93. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., and Borrello, I. (2004). High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64, 6337-6343. doi: 10.1158/0008-5472.CAN-04-0757.
94. Serafini, P., Mgebroff, S., Noonan, K., and Borrello, I. (2008). Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68, 5439-5449. doi: 10.1158/0008-5472.CAN-07-6621.
95. Shirota, Y., Shirota, H., and Klinman, D. M. (2012). Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J. Immunol. 188, 1592-1599. doi: 10.4049/jimmunol.1101304.
96. Sinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A., and Ostrand-Rosenberg, S. (2011). Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 117, 5381-5390. doi: 10.1182/blood-2010-11-321752.
97. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., and Ostrand-Rosenberg, S. (2007). Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977-983. doi: 10.4049/jimmunol.179.2.977.
98. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., and Srikrishna, G. (2008). Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181, 4666-4675. doi: 10.4049/jimmunol.181.7.4666.
99. Skabytska, Y., Wolbing, F., Gunther, C., Koberle, M., Kaesler, S., Chen, K. M., et al. (2014). Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41, 762-775. doi: 10.1016/j.immuni.2014.10.009.
100. Smith, T., Pearson, M., Wilcox, K., Cruz, C., Lancaster, M., Robinson-Dunn, B., et al. (1999). Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340, 493-501.
101. Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., et al. (2005). CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells. J. Immunol. 175, 8200-8208. doi: 10.4049/jimmunol.175.12.8200.
102. Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., and Ostrand-Rosenberg, S. (2010). Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70, 68-77. doi: 10.1158/0008-5472.CAN-09-2587.
103. Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., and Albelda, S. M. (2005). Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 11, 6713-6721. doi: 10.1158/1078-0432.CCR-05-0883.
104. Tacke, R. S., Lee, H. C., Goh, C., Courtney, J., Polyak, S. J., Rosen, H. R., et al. (2012). Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55, 343-353. doi: 10.1002/hep.24700.
105. Tebartz, C., Horst, S. A., Sparwasser, T., Huehn, J., Beineke, A., Peters, G., et al. (2015). A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J. Immunol. 194, 1100-1111. doi: 10.4049/jimmunol.1400196.
106. Thurlow, L. R., Hanke, M. L., Fritz, T., Angle, A., Aldrich, A., Williams, S. H., et al. (2011). Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186, 6585-6596. doi: 10.4049/jimmunol.1002794.
107. Tsiganov, E. N., Verbina, E. M., Radaeva, T. V., Sosunov, V. V., Kosmiadi, G. A., Nikitina, I. Y., et al. (2014). Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice. J. Immunol. 192, 4718-4727. doi: 10.4049/jimmunol.1301365.
108. Tu, S., Bhagat, G., Cui, G., Takaishi, S., Kurt-Jones, E. A., Rickman, B., et al. (2008). Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408-419. doi: 10.1016/j.ccr.2008.10.011.
109. Tumino, N., Turchi, F., Meschi, S., Lalle, E., Bordoni, V., Casetti, R., et al. (2015). In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3zeta expression through ELF-1 inhibition. AIDS 29, 2397-2407. doi: 10.1097/QAD.0000000000000871.
110. Van Ginderachter, J. A., Beschin, A., De Baetselier, P., and Raes, G. (2010). Myeloid-derived suppressor cells in parasitic infections. Eur. J. Immunol. 40, 2976-2985. doi: 10.1002/eji.201040911.
111. Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., et al. (2010). 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 70, 3052-3061. doi: 10.1158/0008-5472.CAN-09-3690.
112. Waldron, T. J., Quatromoni, J. G., Karakasheva, T. A., Singhal, S., and Rustgi, A. K. (2013). Myeloid derived suppressor cells: targets for therapy. Oncoimmunology 2:e24117. doi: 10.4161/onci.24117.
113. Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L. X., Cohen, P. A., et al. (2008). Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 181, 3291-3300. doi: 10.4049/jimmunol.181.5.3291.
114. Weidenmaier, C., Goerke, C., and Wolz, C. (2012). Staphylococcus aureus determinants for nasal colonization. Trends Microbiol. 20, 243-250. doi: 10.1016/j.tim.2012.03.004.
115. Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., et al. (1997). The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24, 584-602.
116. Wieland, C. W., van Lieshout, M. H., Hoogendijk, A. J., and van der Poll, T. (2011). Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2. Eur. Respir. J. 37, 848-857. doi: 10.1183/09031936.00076510.
117. Wu, C. T., Hsieh, C. C., Lin, C. C., Chen, W. C., Hong, J. H., and Chen, M. F. (2012). Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells. J. Mol. Med. (Berl.) 90, 1343-1355. doi: 10.1007/s00109-012-0916-x.
118. Wu, G., and Morris, S. M. Jr. (1998). Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (Pt 1), 1-17.
119. Wyllie, D. H., Kiss-Toth, E., Visintin, A., Smith, S. C., Boussouf, S., Segal, D. M., et al. (2000). Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165, 7125-7132. doi: 10.4049/jimmunol.165.12.7125.
120. Xin, H., Zhang, C., Herrmann, A., Du, Y., Figlin, R., and Yu, H. (2009). Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69, 2506-2513. doi: 10.1158/0008-5472.CAN-08-4323.
121. Yang, B., Wang, X., Jiang, J., Zhai, F., and Cheng, X. (2014). Identification of CD244-expressing myeloid-derived suppressor cells in patients with active tuberculosis. Immunol. Lett. 158, 66-72. doi: 10.1016/j.imlet.2013.12.003.
122. Yi, H., Guo, C., Yu, X., Zuo, D., and Wang, X. Y. (2012). Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J. Immunol. 189, 4295-4304. doi: 10.4049/jimmunol.1200086.
123. Youn, J. I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., et al. (2013). Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 14, 211-220. doi: 10.1038/ni.2526.
124. Youn, J. I., Nagaraj, S., Collazo, M., and Gabrilovich, D. I. (2008). Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802. doi: 10.4049/jimmunol.181.8.5791.
125. Young, M. R., Newby, M., and Wepsic, H. T. (1987). Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47, 100-105.
126. Yu, H., Pardoll, D., and Jove, R. (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9, 798-809. doi: 10.1038/nrc2734.
127. Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., et al. (2005). Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65, 3044-3048. doi: 10.1158/0008-5472.CAN-04-4505.
128. Zea, A. H., Rodriguez, P. C., Culotta, K. S., Hernandez, C. P., DeSalvo, J., Ochoa, J. B., et al. (2004). L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell. Immunol. 232, 21-31. doi: 10.1016/j.cellimm.2005.01.004.
129. Zhan, X., Fang, Y., Hu, S., Wu, Y., Yang, K., Liao, C., et al. (2015). IFN-gamma differentially regulates subsets of Gr-1(+)CD11b(+) myeloid cells in chronic inflammation. Mol. Immunol. 66, 451-462. doi: 10.1016/j.molimm.2015.05.011.
130. Zhang, H., Wang, S., Huang, Y., Wang, H., Zhao, J., Gaskin, F., et al. (2015). Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation. Clin. Immunol. 157, 175-186. doi: 10.1016/j.clim.2015.02.001.
131. Zhang, Y. L., Luan, B., Wang, X. F., Qiao, J. Y., Song, L., Lei, R. R., et al. (2013). Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development. PLoS ONE 8:e63775. doi: 10.1371/journal.pone.0063775.
132. Zhang, Z., Louboutin, J. P., Weiner, D. J., Goldberg, J. B., and Wilson, J. M. (2005). Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect. Immun. 73, 7151-7160. doi: 10.1128/IAI.73.11.7151-7160.2005.
133. Zhao, B. G., Vasilakos, J. P., Tross, D., Smirnov, D., and Klinman, D. M. (2014). Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors. J. Immunother. Cancer 2:12. doi: 10.1186/2051-1426-2-12.
134. Zhao, X., Rong, L., Zhao, X., Li, X., Liu, X., Deng, J., et al. (2012). TNF signaling drives myeloid-derived suppressor cell accumulation. J. Clin. Invest. 122, 4094-4104. doi: 10.1172/JCI64115.
135. Zhuang, Y., Cheng, P., Liu, X. F., Peng, L. S., Li, B. S., Wang, T. T., et al. (2015). A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis. Gut 64, 1368-1378. doi: 10.1136/gutjnl-2014-307020.
136. Zoglmeier, C., Bauer, H., Norenberg, D., Wedekind, G., Bittner, P., Sandholzer, N., et al. (2011). CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin. Cancer Res. 17, 1765-1775. doi: 10.1158/1078-0432.CCR-10-2672.